Understanding Moyamoya Disease and Syndrome

Receiving a diagnosis of Moyamoya can feel overwhelming and deeply isolating. Because it is a rare condition, you may never have heard the name until the moment it was applied to you or your child. It is natural to feel a whirlwind of emotions—from fear of the unknown to the heavy weight of a “rare disease” label. Understanding the mechanics of what is happening in the brain is often the first step toward feeling more in control of the journey ahead.

What is Moyamoya?

Moyamoya is a progressive condition where the main arteries that supply blood to the brain—specifically the internal carotid arteries—begin to narrow and eventually close ^[1][2]. As these large vessels tighten, the brain struggles to get the oxygen-rich blood it needs to function.

To compensate for this blockage, the brain attempts to grow a network of tiny, bypass-like blood vessels. On a specialized X-ray of the brain’s blood vessels (an angiogram), these clusters of tiny, fragile vessels look like a “puff of smoke” ^[2][3]. In fact, the word “Moyamoya” comes from the Japanese term for a hazy puff of smoke drifting in the air. While these tiny vessels are the brain’s way of trying to help, they are often too small to provide enough blood, and their fragile walls are prone to leaking or breaking ^[4].

Disease vs. Syndrome: What’s the Difference?

Doctors use two different terms—Moyamoya Disease and Moyamoya Syndrome—to describe where the condition came from. While the “puff of smoke” appearance is the same in both, the underlying cause differs:

• Moyamoya Disease (MMD): This is the “idiopathic” or primary form of the condition. “Idiopathic” means the narrowing happens on its own without being caused by another known medical problem ^[5][6]. It is often bilateral, meaning it affects both the left and right sides of the brain, though it can start on just one side ^[7].
• Moyamoya Syndrome (MMS): This is when the Moyamoya vascular pattern develops because of another underlying health condition ^[8]. Common conditions associated with Moyamoya Syndrome include:
  • Sickle Cell Disease: A blood disorder that can cause chronic damage to vessel walls ^[9].
  • Down Syndrome: Individuals with Down syndrome have a higher risk of developing these vascular changes ^[8].
  • Neurofibromatosis Type 1 (NF1): A genetic condition that affects the growth of nerve cell tissues and can impact blood vessels ^[10].
  • Autoimmune Thyroid Disorders: Conditions like Graves’ disease have been linked to the progression of Moyamoya ^[11].
  • Prior Cranial Radiation: Radiation therapy to the head (often for childhood brain tumors) can sometimes cause these vessels to narrow years later ^[2].

Note: If you are diagnosed with Moyamoya Syndrome, managing your underlying condition (like working with a hematologist for sickle cell disease or an endocrinologist for thyroid disease) will be a core part of your treatment plan.

The Role of Genetics: The RNF213 Gene

Researchers have identified a specific gene called RNF213 that plays a significant role in Moyamoya susceptibility, particularly in people of East Asian descent (Japanese, Korean, and Chinese) ^[12]. A specific variation in this gene, known as p.R4810K, is a strong known genetic risk factor ^[12][13].

However, it is vital to understand that genetics is not destiny. Having the RNF213 gene variation does not guarantee that a person will develop the disease. The penetrance (the likelihood that a gene will actually cause a disease) varies with the exact variant, ancestry, and family history, but it remains low ^[14]. This means the vast majority of people with the RNF213 variant will live their entire lives without ever developing Moyamoya ^[13]. Scientists believe that other environmental triggers or genetic modifiers interact with this susceptibility to actually begin the disease ^[15][14]. A positive genetic test is not a diagnosis on its own, and genetic counseling can help you understand testing for yourself and your family.

How Doctors Confirm the Diagnosis

The diagnosis has evolved over time. While it was once thought that the narrowing had to be on both sides of the brain, current international guidelines now allow for a diagnosis even if only one side is affected (unilateral), provided the characteristic “puff of smoke” terminal internal-carotid findings are present and other causes are ruled out ^[7][5].

To confirm Moyamoya and distinguish it from look-alike conditions (such as atherosclerosis or vasculitis, which is inflammation of the blood vessels), doctors use high-resolution imaging ^[16]. Vessel-wall MRI is a specialized tool that helps doctors look at the wall of the artery itself. While not a definitive single test, it is a helpful adjunct to distinguish Moyamoya from atherosclerosis or vasculitic mimics ^[17][18]. Knowing exactly which type you have helps your care team decide the best way to protect your brain and manage your symptoms moving forward.